Sun et al. found that downexpression of miR-200b was associated with chemotherapeutic resistance in tongue squamous cell carcinoma (TSCC) cell lines by targeting BMI1 [41]. This evidence concerns the gene BMI1 and tongue squamous cell carcinoma.